Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
1791 Results for "
Compound C
" in MedChemExpress (MCE) Product Catalog:
Products (1791)
1791 Results for "Compound C" in MCE Product Catalog:
3
3
3 Cited Publications
Target:
Research Areas:
Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP + cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function .
3
3 Cited Publications
Target:
Research Areas:
hGPR91 antagonist 1 (Compound 4c) is a potent and selective GPR91 antagonist with an IC50 of 7 nM for human GPR91 .
3
3 Cited Publications
Cat. No.: HY-N6954
CAS No.: 76996-27-5
3
Category:
Flavonoids Leguminosae Glycine max (L.) merr Flavones Other Diseases Phenols Polyphenols Plants Disease Research Fields
Target:
3
3 Cited Publications
Target:
Research Areas:
DRI-C21045 (compound 10) is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC50 of 0.17 μM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC50s of 17.1 μM and 4.5 μM, respectively .
2
2 Cited Publications
G0-C14 is a cationic lipid-like compound alkyl-modified polyamidoamine (PAMAM) dendrimer. G0-C14 involves in the preparation of a series of macrophage-targeted nanoparticles (NPs). NPs can be used for agent and vaccine delivery .
2
2 Cited Publications
Cat. No.: HY-W015913S
CAS No.: 142014-11-7
Synonyms: Sodium 2-oxopropanoate-13C3; Acetylformic acid-13C3 sodium
2
2 Cited Publications
Cat. No.: HY-Y1213S
CAS No.: 14762-74-4
2
2 Cited Publications
Target:
Research Areas:
FGF22-IN-1 (compound c1) is a potent CD4 D1 inhibitor. FGF22-IN-1 can be used as immunosuppressive agent .
2
2 Cited Publications
Target:
Research Areas:
ANO1-IN-1 (Compound 9c) is a selective ANO1 channel blocker with an IC50 of 2.56 μM and 15.43 μM against ANO1 and ANO2, respectively. ANO1-IN-1 suppresses strongly proliferation of glioblastoma cells .
2
2 Cited Publications
Target:
Research Areas:
Pfn1-IN-1 (compound C1) is a Pfn1 inhibitor that inhibits the angiogenic capacity of endothelial cells (EC). Pfn1 is a regulator of the actin cytoskeleton, inducing actin polymerization and essential cellular activities. Pfn1-IN-1 inhibits Pfn1-Actin interaction and Actin polymerization.
2
2 Cited Publications
Target:
Research Areas:
IRF5-IN-1 (Compound C5) is a conformationally locked inhibitor for SLC15A4. IRF5-IN-1 blocks the downstream IRF5 activation, inhibits the TLR7/8 signaling pathway. IRF5-IN-1 exhibits anti-inflammatory responses .
2
2 Cited Publications
Target:
Research Areas:
GOT1 inhibitor-1 (compound 2c), a tryptamine-based derivative, acts as a novel, potent and non-covalent inhibitor of glutamate oxaloacetate transaminase 1 (GOT1) with an IC50 of 8.2 uM. GOT1 plays an important role in energy metabolism and Reactive Oxygen Species (ROS) balance. GOT1 inhibitor-1 can be used for the research of pancreatic ductal adenocarcinoma (PDAC) .
2
2 Cited Publications
Target:
Research Areas:
14-3-3η Protein inhibitor 1 (Compound C11) is a 14-3-3η protein inhibitor with a KD of 35 µM. 14-3-3η Protein inhibitor 1 shows inhibitory activities against several typical human liver cancer cell lines. 14-3-3η Protein inhibitor 1 induces cell apoptosis and G1-S cell cycle arrest with good metabolic stability .
1
1 Cited Publications
Target:
Research Areas:
Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis .
1
1 Cited Publications
Target:
Research Areas:
C3a receptor agonist 1 (compound benzeneacetamide) is a potent C3a receptor agonist. C3a receptor agonist 1 has the potential for the research of acute inflammation .
1
1 Cited Publications
Target:
Research Areas:
C/EBPα inducer 1 (compound 78) is a potent inducer of C/EBPα and myeloid differentiation .
1
1 Cited Publications
Cat. No.: HY-N4123
CAS No.: 164991-86-0
Category:
Curculigo orchioides Gaertn. Monophenols Other Diseases Phenols Plants Disease Research Fields Amaryllidaceae
Target:
1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
